Ayala Pharmaceuticals Analyst Ratings
Ayala Pharmaceuticals Analyst Ratings
While ratings are subjective and will change, the latest Ayala Pharmaceuticals (ADXS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Ayala Pharmaceuticals (ADXS) is trading at is $0.73, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2023 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral | |
| 05/30/2023 | 450.74% | Ladenburg Thalmann | → $4 | Upgrades | Neutral → Buy |
| 12/18/2018 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/16/2023 | — | 拉登堡塔爾曼 | 降級 | 買入 → 中性 | |
| 05/30/2023 | 450.74% | 拉登堡塔爾曼 | → 4 美元 | 升級 | 中性 → 買入 |
| 12/18/2018 | — | HC Wainwright & Co. | 降級 | 買入 → 中性 |
What is the target price for Ayala Pharmaceuticals (ADXS)?
阿亞拉制藥（ADXS）的目標價格是多少？
The latest price target for Ayala Pharmaceuticals (OTCQX: ADXS) was reported by Ladenburg Thalmann on November 16, 2023. The analyst firm set a price target for $0.00 expecting ADXS to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
拉登堡·塔爾曼於2023年11月16日公佈了阿亞拉制藥（場外交易代碼：ADXS）的最新目標股價。該分析公司將目標股價定爲0.00美元，預計ADXS將在12個月內跌至12個月內（可能下跌-100.00％）。去年有2家分析公司公佈了評級。
What is the most recent analyst rating for Ayala Pharmaceuticals (ADXS)?
分析師對阿亞拉制藥（ADXS）的最新評級是多少？
The latest analyst rating for Ayala Pharmaceuticals (OTCQX: ADXS) was provided by Ladenburg Thalmann, and Ayala Pharmaceuticals downgraded their neutral rating.
拉登堡·塔爾曼對阿亞拉制藥（OTCQX：ADXS）的最新分析師評級由拉登堡·塔爾曼提供，阿亞拉制藥下調了中性評級。
When is the next analyst rating going to be posted or updated for Ayala Pharmaceuticals (ADXS)?
阿亞拉制藥（ADXS）的下一次分析師評級將在何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ayala Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ayala Pharmaceuticals was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與阿亞拉制藥公司的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。阿亞拉制藥的最新評級是在2023年11月16日公佈的，因此您應該預計下一個評級將在2024年11月16日左右公佈。
Is the Analyst Rating Ayala Pharmaceuticals (ADXS) correct?
分析師對阿亞拉制藥（ADXS）的評級是否正確？
While ratings are subjective and will change, the latest Ayala Pharmaceuticals (ADXS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Ayala Pharmaceuticals (ADXS) is trading at is $0.73, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的阿亞拉制藥（ADXS）評級已下調，目標股價爲0.00美元至0.00美元。阿亞拉制藥（ADXS）目前的交易價格爲0.73美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。
